Histone Deacetylase Inhibitors and Anticancer Therapy

E-ISSN： 1875-5968|2|4|477-484

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.2, Iss.4, 2002-07, pp. : 477-484

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Deacetylase Inhibitors in Cancer Therapy

By Fouladi Maryam

Cancer Investigation, Vol. 24, Iss. 5, 2006-06 ,pp. : 521-527

Informa Healthcare

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 2, 2007-06 ,pp. : 119-134

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Histone Deacetylase Inhibitors

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 3, 2012-01 ,pp. : 247-270

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines

International Journal of Oncology, Vol. 48, Iss. 1, 2016-01 ,pp. : 409-420

Spandidos Publications

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: Recent Insights from Basic to Clinical Knowledge & Patenting of Anti-Cancer Actions

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 131-145

Bentham Science Publishers

Access to resources Recommend Favorite